Prof Maureen Rischmueller
School of Medicine
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Associate Professor Maureen Rischmueller is the Senior Consultant Rheumatologist, Rheumatology Department at The Queen Elizabeth Hospital, and Clinical Associate Professor, Discipline of Medicine, University of Adelaide. Her main research interests are within the realm of inflammatory rheumatic diseases including Sjogren's syndrome, systemic lupus erythematosus, rheumatoid arthritis, and vasculitis. Her translational research program investigates pathogenetic mechanisms, novel auto-antibodies, genetic risk factors, clinical manifestations, and new treatments for autoimmune rheumatic diseases.
| Date | Position | Institution name |
|---|---|---|
| 2016 - ongoing | Senior Consultant Rheumatologist | The Queen Elizabeth Hospital |
| 2016 - ongoing | Consultant Rheumatologist | Royal Darwin Hospital, Darwin |
| 2015 - ongoing | Staff Consultant Rheumatologist | Queen Elizabeth Hospital, Adelaide |
| 2014 - ongoing | Associate Professor | University of Adelaide, Adelaide |
| 2004 - 2015 | Director, Rheumatology Unit | Queen Elizabeth Hospital, Adelaide |
| Date | Title | Institution | Country |
|---|---|---|---|
| 1993 | Fellowship | Royal Australasian College of Physicians, Sydney | Australia |
| 1985 | MBBS | University of Adelaide, Adelaide | Australia |
| Year | Citation |
|---|---|
| 2025 | Lim, Z. F. S., Hoi, A. Y., Vincent, F. B., Ooi, J. D., Morand, E. F., Rischmueller, M., & Ting, Y. T. (2025). Regulatory T cell therapy for Sjögren's disease: From pathogenesis to targeted treatment. Journal of Translational Autoimmunity, 11, 11 pages. |
| 2025 | Wiley, M. M., Radziszewski, M., Khatri, B., Joachims, M. L., Tessneer, K. L., Stolarczyk, A. M., . . . Lessard, C. J. (2025). Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland. Annals of the Rheumatic Diseases, 84(9), 1512-1527. Scopus2 WoS1 Europe PMC3 |
| 2025 | Zheng, B., Nikpour, M., Stevens, W., Proudman, S., Morrisroe, K., Wang, M., . . . Baron, M. (2025). Predicting trajectories of lung function decline in systemic sclerosis–related interstitial lung disease. Rheumatology, 64(11), 5892-5898. Scopus1 WoS1 |
| 2025 | Ramos-Casals, M., Baer, A. N., Brito-Zerón, M. D. P., Hammitt, K. M., Bouillot, C., Retamozo, S., . . . Akasbi, M. (2025). 2023 International Rome consensus for the nomenclature of Sjögren disease. Nature Reviews Rheumatology, 21(7), 426-437. Scopus11 WoS13 Europe PMC10 |
| 2025 | Pelkas, C., Franke, K. B., Vincent, F. B., & Rischmueller, M. (2025). Novel therapies in Sjögren's disease: A systematic review of the literature. Best Practice and Research Clinical Rheumatology, 39(4), 102084. Scopus1 Europe PMC1 |
| 2024 | Lee, A. Y. S., Rischmueller, M., & Reed, J. H. (2024). Seronegative Sjögren Syndrome: A Forgotten Entity?. Journal of Rheumatology, 51(1), 7-9. Scopus4 WoS3 Europe PMC4 |
| 2024 | Eades, L. E., Sines, J., Hoi, A. Y., Liddle, R., Kandane-Rathnayake, R., Morand, E. F., . . . Vincent, F. B. (2024). Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?. Seminars in Arthritis and Rheumatism, 65, 152354-1-152354-7. Scopus7 WoS6 Europe PMC6 |
| 2024 | Gordon, R. A., Nguyen, Y., Foulquier, N., Beydon, M., Gheita, T. A., Hajji, R., . . . Seror, R. (2024). The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation. Seminars in Arthritis and Rheumatism, 65, 6 pages. Scopus3 WoS2 Europe PMC3 |
| 2024 | Lee, A. Y. S., & Rischmueller, M. (2024). The diagnosis and misdiagnosis of Sjögren disease. Internal Medicine Journal, 54(5), 833-835. Scopus5 WoS4 Europe PMC4 |
| 2024 | Mauro, D., Lin, X., Pontarini, E., Wehr, P., Guggino, G., Tang, Y., . . . Ciccia, F. (2024). CD8+ tissue-resident memory T cells are expanded in primary Sjögren's disease and can be therapeutically targeted by CD103 blockade. Annals of the Rheumatic Diseases, 83(10), 1345-1357. Scopus12 WoS11 Europe PMC8 |
| 2024 | Eades, L. E., Hoi, A. Y., Liddle, R., Sines, J., Kandane-Rathnayake, R., Khetan, S., . . . Vincent, F. B. (2024). Systemic lupus erythematosus in Aboriginal and Torres Strait Islander peoples in Australia: addressing disparities and barriers to optimising patient care. The Lancet Rheumatology, 6(10), e713-e726. Scopus5 WoS5 Europe PMC4 |
| 2024 | Rubbert-Roth, A., Kato, K., Haraoui, B., Rischmueller, M., Liu, Y., Khan, N., . . . Xavier, R. M. (2024). Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study. Rheumatology and Therapy, 11(5), 1197-1215. Scopus4 WoS3 Europe PMC3 |
| 2024 | Major, T. J., Takei, R., Matsuo, H., Leask, M. P., Sumpter, N. A., Topless, R. K., . . . Merriman, T. R. (2024). A genome-wide association analysis reveals new pathogenic pathways in gout. Nature Genetics, 56(11), 2392-2406. Scopus41 WoS40 Europe PMC36 |
| 2024 | Major, T. J., Takei, R., Matsuo, H., Leask, M. P., Sumpter, N. A., Topless, R. K., . . . Merriman, T. R. (2024). Correction to: A genome-wide association analysis reveals new pathogenic pathways in gout (Nature Genetics, (2024), 56, 11, (2392-2406), 10.1038/s41588-024-01921-5). Nature Genetics, 56(11), 2577. Scopus1 Europe PMC1 |
| 2023 | Kivitz, A., Wells, A. F., Vargas, J. I., Baraf, H. S. B., Rischmueller, M., Klaff, J., . . . Durez, P. (2023). Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.. Rheumatol Ther, 10(4), 901-915. Scopus5 WoS4 Europe PMC4 |
| 2023 | Fairley, J. L., Hansen, D., Ross, L., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Australian Scleroderma Interest Group. (2023). Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.. Arthritis Research and Therapy, 25(1), 1-13. Scopus15 WoS14 Europe PMC9 |
| 2023 | Brito-Zerón, P., Flores-Chávez, A., Horváth, I. F., Rasmussen, A., Li, X., Olsson, P., . . . Sisó-Almirall, A. (2023). Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study. Eclinicalmedicine, 61, 16 pages. Scopus30 WoS27 Europe PMC21 |
| 2023 | Polmear, J., Hailes, L., Olshansky, M., Rischmueller, M., L'Estrange-Stranieri, E., Fletcher, A. L., . . . Good-Jacobson, K. L. (2023). Targeting BMI-1 to deplete antibody-secreting cells in autoimmunity. Clinical and Translational Immunology, 12(10), e1470-1-e1470-12. Scopus2 WoS1 Europe PMC2 |
| 2023 | Hernández-Molina, G., Kostov, B., Brito-Zerón, P., Vissink, A., Mandl, T., Hinrichs, A. C., . . . De Miguel Campo, B. (2023). Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies. Rheumatology United Kingdom, 62(1), 243-255. Scopus25 WoS22 Europe PMC13 |
| 2023 | Khatri, B., Tessneer, K. L., Rasmussen, A., Aghakhanian, F., Reksten, T. R., Adler, A., . . . Lessard, C. J. (2023). Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (Nature Communications, (2022), 13, 1, (4287), 10.1038/s41467-022-30773-y). Nature Communications, 14(1), 598. Scopus2 |
| 2023 | Flores-Chávez, A., Brito-Zerón, P., Ng, W. F., Szántó, A., Rasmussen, A., Priori, R., . . . Ramos-Casals, M. (2023). Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren’s syndrome. Clinical and Experimental Rheumatology, 41(12), 2437-2447. Scopus6 WoS6 Europe PMC4 |
| 2023 | Brito-Zerón, P., Flores-Chávez, A., Ng, W. F., Horváth, I. F., Rasmussen, A., Priori, R., . . . Ramos-Casals, M. (2023). Exposure to air pollution as an environmental determinant of how Sjögren’s disease is expressed at diagnosis. Clinical and Experimental Rheumatology, 41(12), 2448-2457. Scopus9 WoS9 Europe PMC5 |
| 2022 | Kerick, M., Acosta-Herrera, M., Simeón-Aznar, C. P., Callejas, J. L., Assassi, S., Carreira, P., . . . Ortega-Castro, R. (2022). Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. Npj Genomic Medicine, 7(1), 12 pages. Scopus10 WoS10 Europe PMC9 |
| 2022 | Inanc, N., Kostov, B., Priori, R., Flores-Chavez, A., Carubbi, F., Szántó, A., . . . Brito-Zerón, P. (2022). Safety and efficacy of SARS-CoV-2 vaccination in 1237 patients with primary Sjögren syndrome. Clinical and Experimental Rheumatology, 40(12), 2290-2297. Scopus6 WoS6 Europe PMC4 |
| 2022 | Khatri, B., Tessneer, K. L., Rasmussen, A., Aghakhanian, F., Reksten, T. R., Adler, A., . . . Lessard, C. J. (2022). Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (Nature Communications, (2022), 13, 1, (4287), 10.1038/s41467-022-30773-y). Nature Communications, 13(1), 1 page. Scopus5 WoS5 Europe PMC5 |
| 2022 | Scofield, R. H., Lewis, V. M., Cavitt, J., Kurien, B. T., Assassi, S., Martin, J., . . . Miller, F. W. (2022). 47XXY and 47XXX in Scleroderma and Myositis. Acr Open Rheumatology, 4(6), 528-533. Scopus19 WoS18 Europe PMC15 |
| 2022 | Khatri, B., Tessneer, K. L., Rasmussen, A., Aghakhanian, F., Reksten, T. R., Adler, A., . . . Lessard, C. J. (2022). Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells.. Nature communications, 13(1), 17 pages. Scopus85 WoS76 Europe PMC62 |
| 2021 | Bossini-Castillo, L., Villanueva-Martin, G., Kerick, M., Acosta-Herrera, M., López-Isac, E., Simeón, C. P., . . . Martin, J. (2021). Genomic Risk Score impact on susceptibility to systemic sclerosis. Annals of the Rheumatic Diseases, 80(1), 118-127. Scopus25 Europe PMC21 |
| 2021 | Retamozo, S., Acar-Denizli, N., Horváth, I. F., Ng, W. F., Rasmussen, A., Dong, X., . . . Brito-Zerón, P. (2021). Influence of the age at diagnosis in the disease expression of primary Sjögren's syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium. Clinical and Experimental Rheumatology, 39(6), S166-S174. Scopus38 Europe PMC26 |
| 2021 | Retamozo, S., Acar-Denizli, N., Horvath, I. F., Ng, W. -F., Rasmussen, A., Dong, X., . . . Brito-Zeron, P. (2021). Influence of the age at diagnosis in the disease expression of primary Sjogren's syndrome. Analysis of 12,753 patients from the Sjogren Big Data Consortium. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 39(6), S166-S174. WoS7 |
| 2021 | Takeuchi, T., Rischmueller, M., Blanco, R., Xavier, R. M., Ueki, Y., Atsumi, T., . . . van Vollenhoven, R. F. (2021). Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study. Modern Rheumatology, 31(3), 534-542. Scopus5 WoS5 Europe PMC4 |
| 2021 | Hoa, S., Bernatsky, S., Baron, M., Proudman, S., Stevens, W., Sahhar, J., . . . Zochling, J. (2021). Association Between Immunosuppressive Therapy and Incident Risk of Interstitial Lung Disease in Systemic Sclerosis. Chest, 160(6), 2158-2162. Scopus9 WoS9 Europe PMC7 |
| 2021 | Brito-Zerón, P., Melchor, S., Seror, R., Priori, R., Solans, R., Kostov, B., . . . Sánchez, I. (2021). SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients. Rheumatology United Kingdom, 60(6), 2946-2957. Scopus20 Europe PMC15 |
| 2021 | Lyne, S. A., Downie-Doyle, S., Lester, S. E., Quinlivan, A., Toby Coates, P., Gordon, T. P., & Rischmueller, M. (2021). Primary Sjögren's syndrome in South Australia. Clinical and Experimental Rheumatology, 38(4), S57-S63. Scopus6 Europe PMC6 |
| 2021 | Khadra, Y., Walker, J. G., Hakendorf, P., Proudman, S., Rischmueller, M., Hill, C. L., . . . Roberts-Thomson, P. J. (2021). Scleroderma renal crisis: observations from the South Australian Scleroderma Register. Internal Medicine Journal, 51(2), 235-242. Scopus4 WoS3 Europe PMC2 |
| 2021 | Fairley, J., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2021). Clinical characteristics and survival in systemic sclerosis-mixed connective tissue disease and systemic sclerosis-overlap syndrome. Arthritis Care and Research, 73(5), 732-741. Scopus20 WoS20 Europe PMC15 |
| 2020 | Singh, M., Jackson, K. J. L., Wang, J. J., Schofield, P., Field, M. A., Koppstein, D., . . . Reed, J. H. (2020). Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody. Cell, 180(5), 878-894. Scopus105 WoS106 Europe PMC88 |
| 2020 | van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Mohamed, M. -E. F., Chen, S., . . . Strand, V. (2020). Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-naïve Patients with Moderately to Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Randomized, Double-blind, Active-comparator, Multi-center, Multi-country Trial.. Arthritis & rheumatology (Hoboken, N.J.), 72(10), 1607-1620. Scopus178 WoS110 Europe PMC165 |
| 2020 | Leonardo, N., Lester, S., Whittle, S., & Rischmueller, M. (2020). Review of gout clinic in a tertiary hospital setting.. Intern Med J, 50(1), 117-120. Scopus5 WoS4 Europe PMC4 |
| 2020 | Brito-Zerón, P., Acar-Denizli, N., Ng, W. -F., Horváth, I. F., Rasmussen, A., Seror, R., . . . Sjögren Big Data Consortium. (2020). Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.. Rheumatology (Oxford, England), 59(9), 2350-2359. Scopus77 WoS70 Europe PMC52 |
| 2020 | Patel, S., Morrisroe, K., Proudman, S., Hansen, D., Sahhar, J., Sim, M. R., . . . Australian Scleroderma Interest Group. (2020). Occupational silica exposure in an Australian systemic sclerosis cohort. Rheumatology, 59(12), 3900-3905. Scopus31 WoS29 Europe PMC27 |
| 2020 | Reed, J. H., Verstappen, G. M., Rischmueller, M., & Bryant, V. L. (2020). When B cells break bad: development of pathogenic B cells in Sjögren's syndrome.. Clin Exp Rheumatol, 38(4), S271-S282. Scopus16 Europe PMC7 |
| 2020 | Ramezanpour, M., Hu, H., Lau, A., Liu, S., De Silva, A., Bolt, H., . . . Vreugde, S. (2020). Increased serum IgG4 associates with asthma and tissue eosinophilia in chronic rhinosinusitis patients. Pathogens, 9(10), 1-6. Scopus4 WoS4 Europe PMC3 |
| 2020 | Rubbert-Roth, A., Enejosa, J., Pangan, A. L., Haraoui, B., Rischmueller, M., Khan, N., . . . Xavier, R. M. (2020). Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis.. The New England journal of medicine, 383(16), 1511-1521. Scopus227 WoS242 Europe PMC188 |
| 2020 | Lyne, S. A., Downie-Doyle, S., Lester, S. E., Quinlivan, A., Coates, P. T., Gordon, T. P., & Rischmueller, M. (2020). Primary Sjogren's syndrome in South Australia. Clinical and Experimental Rheumatology, 38(4), S57-S63. |
| 2020 | Acar-Denizli, N., Horváth, I. F., Mandl, T., Priori, R., Vissink, A., Hernandez-Molina, G., . . . Brito-Zerón, P. (2020). Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies. Clinical and Experimental Rheumatology, 38(4), S85-S94. Scopus20 WoS15 Europe PMC8 |
| 2020 | Reed, J. H., Verstappen, G. M., Rischmueller, M., & Bryant, V. L. (2020). When B cells break bad: development of pathogenic B cells in Sjogren's syndrome. Clinical and Experimental Rheumatology, 38(Suppl. 26), S-271-S-282. WoS14 |
| 2019 | Metwally, M., Thabet, K., Bayoumi, A., Nikpour, M., Stevens, W., Sahhar, J., . . . Eslam, M. (2019). IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis. Scientific Reports, 9(1), 14834. Scopus24 WoS19 Europe PMC16 |
| 2019 | López-Isac, E., Acosta-Herrera, M., Kerick, M., Assassi, S., Satpathy, A. T., Granja, J., . . . Chang, H. Y. (2019). GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nature Communications, 10(1), 14 pages. Scopus135 WoS131 Europe PMC130 |
| 2019 | Vincent, F. B., Lang, T., Kandane-Rathnayake, R., Downie-Doyle, S., Morand, E. F., & Rischmueller, M. (2019). Serum and urinary macrophage migration inhibitory factor (MIF) in primary Sjögren's syndrome. Joint Bone Spine, 86(3), 393-395. Scopus3 WoS4 Europe PMC3 |
| 2019 | Retamozo, S., Acar-Denizli, N., Rasmussen, A., Horvath, I. F., Baldini, C., Priori, R., . . . Brito-Zeron, P. (2019). Systemic Manifestations of Primary Sjogren Syndrome out of the ESSDAI Classification: Prevalence and Clinical Relevance in a Large International, Multi-ethnic Cohort of Patients. ARTHRITIS & RHEUMATOLOGY, 71(3), 4 pages. Europe PMC33 |
| 2019 | Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay, F., Morand, E. F., & Rischmueller, M. (2019). Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome. Clinical and Experimental Rheumatology, 37(3), S254-S256. Scopus5 WoS1 |
| 2019 | Retamozo, S., Acar-Denizli, N., Rasmussen, A., Horváth, I. F., Baldini, C., Priori, R., . . . Brito-Zerón, P. (2019). Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. Clinical and experimental rheumatology, 37(3), S97-S106. Scopus71 WoS41 |
| 2019 | Acar-Denizli, N., Kostov, B., Ramos-Casals, M., Brito-Zerón, P., Morcillo, C., Flores-Chávez, A., . . . Perdriger, A. (2019). The Big Data Sjögren consortium: A project for a new data science era. Clinical and Experimental Rheumatology, 37(3), S19-S23. Scopus22 Europe PMC6 |
| 2019 | van der Heijde, D., Strand, V., Tanaka, Y., Keystone, E., Kremer, J., Zerbini, C. A. F., . . . Wagh, S. (2019). Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four–Month, Phase III Study. Arthritis and Rheumatology, 71(6), 878-891. Scopus92 Europe PMC66 |
| 2019 | Richard, N., Hudson, M., Wang, M., Gyger, G., Proudman, S., Stevens, W., . . . Baron, M. (2019). Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality. Rheumatology, 58(4), 636-644. Scopus48 WoS54 Europe PMC34 |
| 2019 | Butler, E. A., Baron, M., Fogo, A. B., Frech, T., Ghossein, C., Hachulla, E., . . . Walker, U. A. (2019). Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology. Arthritis and Rheumatology, 71(6), 964-971. Scopus52 WoS46 Europe PMC38 |
| 2019 | Rischmueller, M., & Spurrier, A. (2019). Can Sjögren’s syndrome diagnosis and evaluation be stretched by elastography?. International Journal of Rheumatic Diseases, 22(2), 172-174. Scopus2 WoS1 Europe PMC1 |
| 2019 | Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay, F., Morand, E. F., & Rischmueller, M. (2019). Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome.. Clinical and experimental rheumatology, 37 Suppl 118(3), 254-256. Europe PMC3 |
| 2019 | Ferdowsi, N., Huq, M., Stevens, W., Hudson, M., Wang, M., Tay, T., . . . Nikpour, M. (2019). Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): A novel instrument to quantify organ damage in systemic sclerosis. Annals of the Rheumatic Diseases, 78(6), 807-816. Scopus55 WoS57 Europe PMC34 |
| 2018 | Hsu, V., Denton, C., Domsic, R., Furst, D., Rischmueller, M., Stanislav, M., . . . Hough, D. (2018). Pomalidomide in patients with interstitial lung disease due to systemic sclerosis: A phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Journal of Rheumatology, 45(3), 405-410. Scopus35 WoS33 Europe PMC30 |
| 2018 | Hall, S., Nash, P., Rischmueller, M., Bossingham, D., Bird, P., Cook, N., . . . Thirunavukkarasu, K. (2018). Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population.. Rheumatology and therapy, 5(2), 383-401. Scopus13 WoS10 Europe PMC9 |
| 2018 | Retamozo, S., Acar-Denizli, N., Ng, W. -F., Zeher, M., Rasmussen, A., Mandl, T., . . . Brito-Zeron, P. (2018). How Immunological Profile Drives Clinical Phenotype of Primary Sjogren's Syndrome at Diagnosis: Analysis of 10.500 Patients (Sjogren Big Data Project). Clinical and Experimental Rheumatology, 36(Suppl 112), S102-S111. Scopus160 Europe PMC73 |
| 2018 | Vincent, F. B., Kandane-Rathnayake, R., Hoi, A. Y., Slavin, L., Godsell, J. D., Kitching, A. R., . . . Morand, E. F. (2018). Urinary B-cell-activating factor of the tumour necrosis factor family (BAFF) in systemic lupus erythematosus. Lupus, 27(13), 2029-2040. Scopus21 WoS19 Europe PMC16 |
| 2018 | Harris, V., Sharma, R., Cavett, J., Kurien, B., Liu, K., Koelsch, K., . . . Scofield, R. (2018). Corrigendum to “Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome” [Clin. Immunol. 168 (2016) 25–29](S1521661616300614)(10.1016/j.clim.2016.04.002). Clinical Immunology, 187, 137-138. Scopus1 WoS1 Europe PMC1 |
| 2017 | Lau, A., Lester, S., Moraitis, S., Ou, J., Psaltis, A., McColl, S., . . . Vreugde, S. (2017). Tertiary lymphoid organs in recalcitrant chronic rhinosinusitis. Journal of Allergy and Clinical Immunology, 139(4), 1371-1373. Scopus25 WoS23 Europe PMC18 |
| 2017 | Brito-Zerón, P., Acar-Denizli, N., Zeher, M., Rasmussen, A., Seror, R., Theander, E., . . . Ramos-Casals, M. (2017). Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium. Annals of the Rheumatic Diseases, 76(6), 1042-1050. Scopus178 WoS155 Europe PMC112 |
| 2017 | Nossent, J., Lester, S., Rischmueller, M., & Zalewski, P. (2017). No zinc deficiency but a putative immunosuppressive role for labile Zn in patients with systemic autoimmune disease. Current Rheumatology Reviews, 13(1), 59-64. Scopus4 WoS4 Europe PMC3 |
| 2017 | Morrisroe, K., Stevens, W., Sahhar, J., Rabusa, C., Nikpour, M., Proudman, S., . . . Zochling, J. (2017). Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme. Arthritis Research and Therapy, 19(1), 42-1-42-10. Scopus79 WoS75 Europe PMC59 |
| 2017 | Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G., Zochling, J., . . . ustralian Scleroderma Interest Group (ASIG). (2017). Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis. Clinical and Experimental Rheumatology, 35(4 Suppl. 106), S130-S137. Scopus11 WoS6 Europe PMC15 |
| 2017 | Maundrell, A., Lester, S., Rischmueller, M., Hill, C., Cleland, L. G., Blumbergs, P., . . . Limaye, V. (2017). The PTPN22 gene is associated with idiopathic inflammatory myopathy. Muscle and Nerve, 55(2), 270-273. Scopus4 WoS4 Europe PMC2 |
| 2017 | Morrisroe, K., Stevens, W., Huq, M., Prior, D., Sahhar, J., Ngian, G., . . . Walker, J. (2017). Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension. Arthritis Research and Therapy, 19(1), 122. Scopus64 WoS64 Europe PMC51 |
| 2017 | Li, H., Reksten, T. R., Ice, J. A., Kelly, J. A., Adrianto, I., Rasmussen, A., . . . Sivils, K. L. (2017). Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genetics, 13(6), 29 pages. Scopus70 WoS67 Europe PMC70 |
| 2017 | Sharma, R., Harris, V., Cavett, J., Kurien, B., Liu, K., Koelsch, K., . . . Scofield, R. (2017). Rare X Chromosome Abnormalities in Systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis and Rheumatology, 69(11), 2187-2192. Scopus48 WoS42 Europe PMC38 |
| 2017 | Morrisroe, K., Stevens, W., Huq, M., Sahhar, J., Ngian, G. S., Zochling, J., . . . Walker, J. (2017). Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosis. Journal of Scleroderma and Related Disorders, 2(3), 188-195. Scopus13 WoS14 |
| 2017 | Proudman, S. M., Huq, M., Stevens, W., Wilson, M. E., Sahhar, J., Baron, M., . . . Hij, A. (2017). What have multicentre registries across the world taught us about the disease features of systemic sclerosis?. Journal of Scleroderma and Related Disorders, 2(3), 169-182. Scopus23 WoS23 |
| 2017 | Fleischmann, R., Mysler, E., Hall, S., Kivitz, A. J., Moots, R. J., Luo, Z., . . . Walczak, A. (2017). Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial. Lancet, 390(10093), 457-468. Scopus433 Europe PMC331 |
| 2016 | Rischmueller, M., Tieu, J., & Lester, S. (2016). Primary Sjögren's syndrome. Best Practice and Research: Clinical Rheumatology, 30(1), 189-220. Scopus97 WoS89 Europe PMC65 |
| 2016 | Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Sahhar, J., G Walker, J., . . . Nikpour, M. (2016). The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. Clinical and Experimental Rheumatology, 34(5 (Suppl.100)), 129-136. Scopus20 WoS10 Europe PMC12 |
| 2016 | Rasheed, H., Phipps-Green, A. J., Topless, R., Smith, M. D., Hill, C., Lester, S., . . . Merriman, T. R. (2016). Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout. Rheumatology, 55(8), 1421-1430. Scopus17 WoS13 Europe PMC15 |
| 2016 | Wechalekar, M., Lester, S., Hill, C., Lee, A., Rischmueller, M., Smith, M., . . . Proudman, S. (2016). Active foot synovitis in patients with rheumatoid arthritis: unstable remission status, radiographic progression, and worse functional outcomes in patients with foot synovitis in apparent remission. Arthritis Care and Research, 68(11), 1616-1623. Scopus36 WoS35 Europe PMC27 |
| 2016 | Lester, S., Hewitt, A., Ruediger, C., Bradbury, L., De Smit, E., Wiese, M., . . . Hill, C. (2016). PTPN22 R620W minor allele is a genetic risk factor for giant cell arteritis. RMD Open, 2(1), e000246-1-e000246-3. Scopus8 WoS10 Europe PMC5 |
| 2016 | Harris, V., Sharma, R., Cavett, J., Kurien, B., Liu, K., Koelsch, K., . . . Scofield, R. (2016). Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome. Clinical Immunology, 168, 25-29. Scopus86 WoS75 Europe PMC76 |
| 2016 | Liu, K., Kurien, B., Zimmerman, S., Kaufman, K., Taft, D., Kottyan, L., . . . Hal Scofield, R. (2016). X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic lupus erythematosus and Sjögren's syndrome. Arthritis and Rheumatology, 68(5), 1290-1300. Scopus141 WoS132 Europe PMC119 |
| 2015 | Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. J. (2015). Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects. Autoimmunity, 48(8), 542-551. Scopus32 WoS28 Europe PMC24 |
| 2015 | Wechalekar, M. D., Lester, S., Rischmueller, M., Hill, C., & Proudman, S. (2015). Foot Synovitis in Patients with Rheumatoid Arthritis in Apparent Remission Is Associated with Unstable Remission Status, Radiographic Progression and Worse Long-Term Functional Outcomes. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. |
| 2015 | Patterson, K., Roberts-Thomson, P., Lester, S., Tan, J., Hakendorf, P., Rischmueller, M., . . . Walker, J. (2015). Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (Scleroderma) cohort using principal components analysis. Arthritis and Rheumatology, 67(12), 3234-3244. Scopus104 WoS97 Europe PMC71 |
| 2015 | Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Salazar, G. (2015). Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: Evidence of an association with interstitial lung disease and worse survival. Clinical and Experimental Rheumatology, 33(4 (suppl.91)), 131-135. Scopus67 WoS62 Europe PMC48 |
| 2015 | Quinlivan, A., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2015). Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Internal Medicine Journal, 45(11), 1134-1140. Scopus21 WoS21 Europe PMC17 |
| 2015 | Merriman, T. R., Phipps-Green, A., Topless, R., Smith, M. D., Hill, C., Lester, S., . . . Rasheed, H. (2015). Association of the Apolipoprotein A1-C3-A4 Gene Cluster with the Risk of Gout: Evidence for a Causal Role in Gout. ARTHRITIS & RHEUMATOLOGY, 67, 2 pages. |
| 2015 | Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2015). A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis. Arthritis Research and Therapy, 17(1), 23. Scopus103 WoS102 Europe PMC85 |
| 2015 | Kottyan, L., Zoller, E., Bene, J., Lu, X., Kelly, J., Rupert, A., . . . Kaufman, K. (2015). The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human Molecular Genetics, 24(2), 582-596. Scopus71 WoS68 Europe PMC64 |
| 2015 | Proudman, S., James, M., Spargo, L., Metcalf, R., Sullivan, T., Rischmueller, M., . . . Cleland, L. (2015). Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. Annals of the Rheumatic Diseases, 74(1), 89-95. Scopus130 WoS114 Europe PMC97 |
| 2014 | Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Black, R., Ahern, M., . . . Hill, C. (2014). Epidemiology of biopsy-proven giant cell arteritis in South Australia. Internal Medicine Journal, 44(1), 32-39. Scopus62 WoS56 Europe PMC48 |
| 2014 | Dunstan, E., Lester, S., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2014). TLR4 polymorphism is not associated with biopsy proven giant cell arteritis. Clinical and Experimental Rheumatology, 32(SUPPL.82), S26-S29. Scopus4 WoS4 Europe PMC4 |
| 2014 | Zochling, J., Newell, F., Charlesworth, J., Leo, P., Stankovich, J., Cortes, A., . . . Brown, M. (2014). An immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3. Arthritis Research & Therapy, 16(5), 438-1-438-7. Scopus64 WoS54 Europe PMC44 |
| 2014 | Lester, S., Hewitt, A., Bradbury, L., De Smit, E., Harrison, A., Jones, G., . . . Hill, C. L. (2014). PTPN22 rs2476601 and Susceptibility to Biopsy Proven Giant Cell Arteritis (GCA) in an Australian Sample.. ARTHRITIS & RHEUMATOLOGY, 66, S341. |
| 2013 | Lester, S., Nossent, J., & Rischmueller, M. (2013). Comment on 'No association of primary Sjögren's syndrome with Fcγ receptor gene variants'. Genes and Immunity, 14(8), 530-531. Scopus1 WoS1 |
| 2013 | Dunstan, E., Lester, S., Black, R., Rischmueller, M., Chan, H., Hewitt, A., & Hill, C. (2013). No association between FCγR3B copy number variation and susceptibility to biopsy-proven giant cell arteritis. Arthritis, 2013, 514914-1-514914-4. WoS1 Europe PMC1 |
| 2013 | Jardeleza, C., Miljkovic, D., Baker, L., Boase, S., Tan, N., Koblar, S., . . . Vreugde, S. (2013). Inflammasome gene expression alterations in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Rhinology, 51(4), 315-322. Scopus14 WoS12 Europe PMC11 |
| 2013 | Lessard, C., & Rischmueller, M. (2013). Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren's syndrome. Nature Genetics, 45(11), 1284-1294. Scopus454 WoS417 Europe PMC384 |
| 2013 | Lester, S., Stokes, L., Skarratt, K., Gu, B., Sivils, K., Lessard, C., . . . Rischmueller, M. (2013). Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome. Arthritis Research & Therapy, 15(4), 1-10. Scopus21 WoS20 Europe PMC15 |
| 2013 | Tan, J., & Rischmueller, M. (2013). Sjogren's syndrome in 2013. Medicine Today, 14(6), 26-35. Scopus1 |
| 2013 | Nossent, J., Becker-Merok, A., Rischmueller, M., & Lester, S. (2013). Susceptibility for lupus nephritis by low copy number of the FCGR3B gene is linked to increased levels of pathogenic autoantibodies. Autoimmune Diseases, 2013, 1-7. Scopus9 WoS7 Europe PMC7 |
| 2013 | Black, R., Roach, D., Rischmueller, M., Lester, S., & Hill, C. (2013). The use of temporal artery ultrasound in the diagnosis of giant cell arteritis in routine practice. International Journal of Rheumatic Diseases, 16(3), 352-357. Scopus17 WoS15 Europe PMC15 |
| 2013 | Thakkar, V., Stevens, W., Prior, D., Youssef, P., Liew, D., Gabbay, E., . . . Nikpour, M. (2013). The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Research & Therapy, 15(6), R193-1-R193-11. Scopus64 WoS61 Europe PMC51 |
| 2013 | Usmani, Z., Hlavac, M., Rischmueller, M., Heraganahally, S., Hilditch, C., Lester, S., . . . McEvoy, R. (2013). Response to: The interaction of Sjogren's syndrome, gastroesophageal reflux and sleep by Tufik et al.. Sleep Medicine, 14(2), 222-223. |
| 2013 | Dunstan, E., Lester, S., Rischmueller, M., Dodd, T., Ahern, M., Cleland, L., . . . Hill, C. (2013). EPIDEMIOLOGY OF BIOPSY-PROVEN GIANT CELL ARTERITIS (GCA) IN SOUTH AUSTRALIA. INTERNAL MEDICINE JOURNAL, 43, 21. |
| 2013 | McInnes, I. B., Kavanaugh, A., Gottlieb, A. B., Puig, L., Rahman, P., Ritchlin, C., . . . Sterry, W. (2013). Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet, 382(9894), 780-789. Scopus734 Europe PMC541 |
| 2012 | Black, R., Roach, D., Lester, S., Rischmueller, M., & Hill, C. (2012). THE USE OF TEMPORAL ARTERY ULTRASOUND IN THE DIAGNOSIS OF GIANT CELL ARTERITIS AT THE QUEEN ELIZABETH HOSPITAL. INTERNAL MEDICINE JOURNAL, 42, 24. WoS1 |
| 2012 | Nossent, J., Rischmueller, M., & Lester, S. (2012). Low copy number of the Fc-γ receptor ₃B gene FCGR₃B is a risk factor for primary Sjögren's syndrome. Journal of Rheumatology, 39(11), 2142-2147. Scopus33 WoS31 Europe PMC30 |
| 2012 | Usmani, Z., Hlavac, M., Rischmueller, M., Heraganahally, S., Hilditch, C., Lester, S., . . . McEvoy, R. (2012). Sleep disordered breathing in patients with primary Sjögren's syndrome: A group controlled study. Sleep Medicine, 13(8), 1066-1070. Scopus47 WoS41 Europe PMC33 |
| 2012 | Lester, S., Rischmueller, M., Tan, L., Wormald, P., Zalewski, P., Hamilton-Bruce, M., . . . Hill, C. (2012). Sicca symptoms and their association with chronic rhinosinusitis in a community sample. The Open Rheumatology Journal, 6(1), 170-174. Scopus8 Europe PMC6 |
| 2012 | Black, R., Lester, S., Dunstan, E., Shahram, F., Nadji, A., Bayat, N., . . . Davatchi, F. (2012). Fc-gamma receptor 3B copy number variation is not a risk factor for Behçet’s disease. International Journal of Rheumatology, 2012, 1-4. Scopus5 WoS7 Europe PMC5 |
| 2012 | Graf, S., Lester, S., Nossent, J., Hill, C., Proudman, S., Lee, A., & Rischmueller, M. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case-control study and meta-analysis. Arthritis Research & Therapy, 14(1), 1-7. Scopus34 WoS35 Europe PMC32 |
| 2012 | Wechalekar, M., Lester, S., Proudman, S., Cleland, L., Whittle, S., Rischmueller, M., & Hill, C. (2012). Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvement. Arthritis and Rheumatism, 64(5), 1316-1322. Scopus51 WoS49 Europe PMC40 |
| 2012 | Tran, H., Lewis, M., Tan, L. W., Lester, S., Baker, L., Ng, J., . . . Lang, C. (2012). Immunolocalization of NLRP3 inflammasome in normal murine airway epithelium and changes following induction of ovalbumin-induced airway inflammation. Journal of Allergy, Online(819176), 1-13. Europe PMC43 |
| 2011 | Ninan, J., Nguyen, A., Cole, A., Rischmueller, M., Dodd, T., Roberts-Thomson, P., & Hill, C. (2011). Mortality in patients with biopsy-proven giant cell arteritis: A South Australian population-based study. Journal of Rheumatology, 38(10), 2215-2217. Scopus49 WoS47 Europe PMC36 |
| 2011 | Tran, H., Rischmueller, M., Lester, S., Tan, L., Lewis, M., Koblar, S., . . . Zalewski, P. (2011). INFLAMMASOME ACTIVATION IS IMPLICATED IN DISEASE PATHOGENESIS IN ASTHMA AND PRIMARY SJOGREN'S SYNDROME. INTERNAL MEDICINE JOURNAL, 41, 9. |
| 2011 | Gilboa-Geffen, A., Wolf, Y., Hanin, G., Melamed-Book, N., Pick, M., Bennett, E. R., . . . Soreq, H. (2011). Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome. Plos One, 6(12), e28727. Scopus28 Europe PMC23 |
| 2010 | Cobb, B. L., Fei, Y., Jonsson, R., Bolstad, A. I., Brun, J. G., Rischmueller, M., . . . Sawalha, A. H. (2010). Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjögren's syndrome. Annals of the Rheumatic Diseases, 69(9), 1731-1732. Scopus31 WoS28 Europe PMC25 |
| 2010 | Wechalekar, M. D., Rischmueller, M., Whittle, S., Burnet, S., & Hill, C. L. (2010). Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab. Journal of Clinical Rheumatology, 16(2), 79-80. Scopus20 WoS15 Europe PMC13 |
| 2010 | Hill, C., Cole, A., Rischmueller, M., Dodd, T., Coleman, M., Tucker, G., & Roberts-Thomson, P. (2010). Risk of cancer in patients with biopsy-proven giant cell arteritis. Rheumatology, 49(4), 756-759. Scopus20 WoS21 Europe PMC17 |
| 2010 | Hill, C. L., Cole, A., Rischmueller, M., Dodd, T., Coleman, M., Tucker, G., & Roberts-Thomson, P. (2010). Risk of cancer in patients with biopsy-proven giant cell arteritis (vol 49, pg 756, 2010). RHEUMATOLOGY, 49(11), 2230. |
| 2008 | Tak, P., Thurlings, R., Rossier, C., Nestorov, I., Dimic, A., Mircetic, V., . . . Munafo, A. (2008). Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study. Arthritis and Rheumatism, 58(1), 67-72. Scopus193 Europe PMC151 |
| 2008 | Nossent, J., Lester, S., Zahra, D., Mackay, C., & Rischmueller, M. (2008). Polymorphism in the 5 ' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome. Rheumatology, 47(9), 1311-1316. Scopus62 WoS57 Europe PMC49 |
| 2008 | Cai, F., Lester, S., Lu, T., Keen, H., Boundy, K., Proudman, S., . . . Rischmueller, M. (2008). Mild autonomic dysfunction in primary Sjogren's syndrome: a controlled study. Arthritis Research & Therapy, 10(2), R31-1-R31-10. Scopus40 WoS34 Europe PMC28 |
| 2008 | Lester, S., McLure, C., Williamson, J., Bardy, P., Rischmueller, M., & Dawkins, R. (2008). Epistasis between the MHC and the RCAα block in primary Sjögren syndrome. Annals of the Rheumatic Diseases, 67(6), 849-854. Scopus15 WoS14 Europe PMC9 |
| 2008 | Cobb, B., Kaufman, K., Wang, Y., Kelly, J., Jonsson, R., Bolstad, A., . . . Harley, J. (2008). Association of Sjögren's syndrome (SS) and systemic lupus erythematosus (SLE) with BLK. Clinical Immunology, 127 Suppl, S41. |
| 2008 | Hilditch, C., McEvoy, R., George, K., Thompson, C., Ryan, M., Rischmueller, M., & Catcheside, P. (2008). Upper airway surface tension but not upper airway collapsibility is elevated in primary Sjogren's syndrome. Sleep, 31(3), 367-374. Scopus27 WoS24 Europe PMC23 |
| 2007 | Proudman, S., Keen, H., Stamp, L., Lee, A., Goldblatt, F., Ayres, O., . . . Cleland, L. (2007). Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. Seminars in Arthritis and Rheumatism, 37(2), 99-111. Scopus64 WoS65 Europe PMC54 |
| 2007 | Lester, S., Downie-Doyle, S., & Rischmueller, M. (2007). CTLA4 polymorphism and primary Sjögren's syndrome. Arthritis Research and Therapy, 9(3), 1 page. Scopus3 WoS3 Europe PMC2 |
| 2006 | Tsopelas, C., Penglis, P., Miller, D., Rischmueller, M., & Bartholomeusz, F. (2006). Evaluation of Tc-99m-immunoglobulins for imaging infection in the rat. Journal of Labelled Compounds & Radiopharmaceuticals, 49(10), 915-928. Scopus2 WoS1 |
| 2006 | Downie-Doyle, S., Bayat, N., Rischmueller, M., & Lester, S. (2006). Influence of CTLA4 haplotypes on susceptibility and some extraglandular manifestations in primary Sjogren's syndrome. Arthritis and Rheumatism, 54(8), 2434-2440. Scopus58 WoS54 Europe PMC44 |
| 2005 | Smith, A., Jackson, M., Wang, F., Cavill, D., Rischmueller, M., & Gordon, T. (2005). Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome. Human Immunology, 66(4), 411-416. Scopus35 WoS31 Europe PMC26 |
| 2005 | Cox, S., Walker, J., Coleman, M., Rischmueller, M., Proudman, S., Smith, M., . . . Roberts-Thomson, P. (2005). Isolated pulmonary hypertension in scleroderma. Internal Medicine Journal, 35(1), 28-33. Scopus65 WoS60 Europe PMC45 |
| 2004 | Mullighan, C., Heatley, S., Lester, S., Rischmueller, M., Gordon, T., & Bardy, P. (2004). Fas gene promoter polymorphisms in primary Sjogren's syndrome. Annals of the Rheumatic Diseases, 63(1), 98-101. Scopus22 WoS23 Europe PMC31 |
| 2003 | Cai, F., Rischmueller, M., Pile, K., & Brady, S. (2003). Dysphagia associated with lower thoracic spondylosis. Rheumatology, 42(12), 1575-1576. Scopus8 WoS8 Europe PMC6 |
| 2003 | Walker, J., Gordon, T., Lester, S., Downie-Doyle, S., McEvoy, R., Pile, K., . . . Rischmueller, M. (2003). Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome. Journal of Rheumatology, 30(11), 2406-2412. Scopus58 WoS55 Europe PMC43 |
| 2003 | Walker, J., Ahern, M., Smith, M., Coleman, M., Pile, K., Rischmueller, M., . . . Roberts-Thomson, P. (2003). Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Internal Medicine Journal, 33(5-6), 216-220. Scopus63 WoS55 Europe PMC45 |
| 2003 | Lester, S., Danda, D., Cavill, D., Pile, K., Downie-Doyle, S., & Rischmueller, M. (2003). Humoral immunity to Ro52 is not associated with the Ro52 9571 C/T polymorphism in Australian patients with primary Sjögren's syndrome. Arthritis and Rheumatism, 48(11), 3293-3294. Scopus2 WoS2 Europe PMC1 |
| 2003 | Iyngkaran, P., Limaye, V., Hill, C., Henderson, D., Pile, K. D., & Rischmueller, M. (2003). Rheumatoid vasculitis following influenza vaccination [7]. Rheumatology, 42(7), 907-909. Scopus29 WoS27 Europe PMC21 |
| 2002 | Lester, S., Limaye, V., Downie-Doyle, S., Pile, K. D., Bardy, P., Gordon, T. P., . . . Hurme, M. (2002). No evidence of an association between the interleukin-10 promoter GCC allele and primary Sjögren's syndrome: Comment on the article by Hulkkonen et al (multiple letters) [3]. Arthritis and Rheumatism, 46(6), 1694-1696. Scopus3 WoS3 Europe PMC3 |
| 2002 | Downie-Doyle, S., Lester, S., Bardy, P., Gordon, T., Rischmueller, M., & Pile, K. (2002). Immunoglobulin kappa light chain gene alleles are not associated with primary Sjogren's Syndrome. Genes and Immunity, 3(Suppl 1), S63-S65. Scopus5 WoS5 Europe PMC3 |
| 2001 | Burnet, S., Mahadevan, G., Lee, A., & Rischmueller, M. (2001). Sacral insufficiency fracture - A case of post-coital back pain [2]. Rheumatology, 40(9), 1065-1066. Scopus5 Europe PMC3 |
| 2001 | Limaye, V., Lester, S., Downie-Doyle, S., Pile, K., Bardy, P., Gordon, T. P., & Rischmueller, M. (2001). Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjogren's syndrome (vol 27, pg 2945, 2000). JOURNAL OF RHEUMATOLOGY, 28(3), 684. WoS2 |
| 2001 | Gordon, T. P., Bolstad, A. I., Rischmueller, M., Jonsson, R., & Waterman, S. A. (2001). Autoantibodies in primary Sjögren's syndrome: New insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity, 34(2), 123-132. Scopus86 Europe PMC66 |
| 2001 | Rischmueller, M., Limaye, V., & Lester, S. (2001). Erratum: Polymorphisms of the interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjögren's syndrome (Journal of Rheumatology (2000) 27 (2945-2949)). Journal of Rheumatology, 28(3), 684. |
| 2000 | Goldblatt, F., Beroukas, D., Gillis, D., Cavill, D., Bradwell, A., Rischmueller, M., & Gordon, T. P. (2000). Antibodies to ab blood group antigens mimic anti-salivary duct autoantibodies in patients with limited sicca symptoms. Journal of Rheumatology, 27(10), 2382-2388. Scopus9 WoS6 Europe PMC5 |
| 2000 | Mullighan, C. G., Heatley Sue, B., Bardy, P. G., Lester, S., Rischmueller, M., & Gordon, T. P. (2000). Lack of association between mannose-binding lectin gene polymorphisms and primary Sjogren's syndrome. Arthritis and Rheumatism, 43(12), 2851-2852. Scopus14 WoS15 Europe PMC10 |
| 2000 | Couper, J., Kallincos, N., Pollard, A., Honeyman, M., Prager, P., Harrison, L., & Rischmueller, M. (2000). Toxic shock syndrome associated with newly diagnosed type 1 diabetes. Journal of Paediatrics and Child Health, 36(3), 279-282. Scopus7 WoS6 Europe PMC5 |
| 2000 | Limaye, V., Lester, S., Downie-Doyle, S., Pile, K., Rischmueller, M., Bardy, P., & Gordon, T. (2000). Polymorphisms of the Interleukin 10 gene promoter are not associated with anti-Ro autoantibodies in primary Sjgren's Syndrome. Journal of Rheumatology, 27(12), 2945-2946. Scopus18 WoS20 Europe PMC13 |
| 2000 | Waterman, S. A., Gordon, T. P., & Rischmueller, M. (2000). Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome. Arthritis and Rheumatism, 43(7), 1647-1654. Scopus236 WoS209 Europe PMC158 |
| 1999 | Coates, T., Slavotinek, J., Rischmueller, M., Schultz, D., Anderson, C., Dellamelva, M., . . . Gordon, T. (1999). Cerebral white matter lesions in primary sjogren's syndrome: a controlled study. Journal of Rheumatology, 26(6), 1301-1305. Scopus73 WoS61 Europe PMC44 |
| 1998 | McCluskey, J., Farris, A. D., Keech, C. L., Purcell, A. W., Rischmueller, M., Kinoshita, G., . . . Gordon, T. P. (1998). Determinant spreading: Lessons from animal models and human disease. Immunological Reviews, 164(1), 209-229. Scopus125 Europe PMC87 |
| 1998 | Rischmueller, M., Lester, S., Chen, Z., Champion, G., Van Den Berg, R., Beer, R., . . . Gordon, T. (1998). HLA class II phenotype controls diversification of the autoantibody response in primary Sjogren's syndrome (pSS). Clinical and Experimental Immunology, 111(2), 365-371. Scopus95 WoS80 Europe PMC67 |
| 1997 | Burrows, S. R., Silins, S. L., Cross, S. M., Peh, C. A., Rischmueller, M., Burrows, J. M., . . . McCluskey, J. (1997). Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire. European Journal of Immunology, 27(1), 178-182. Scopus35 WoS33 Europe PMC34 |
| 1997 | Burrows, S. R., Silins, S. L., Khanna, R., Burrows, J. M., Rischmueller, M., McCluskey, J., & Moss, D. J. (1997). Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: Degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. European Journal of Immunology, 27(7), 1726-1736. Scopus160 Europe PMC137 |
| 1996 | Rischmueller, M., Davies, R. P., & Smith, M. D. (1996). Three year follow-up of a case of giant cell arteritis presenting with a chronic couch and upper limb ischaemic symptoms. British Journal of Rheumatology, 35(8), 800-802. Scopus17 Europe PMC11 |
| 1996 | Rischmueller, M., Lester, S., McCluskey, J., Beer, R., Coates, T., & Gordon, T. P. (1996). Non-precipitating and precipitating anti-La(SS-B) autoantibodies in primary Sjogren's syndrome are associated with distinct MHC phenotypes.. ARTHRITIS AND RHEUMATISM, 39(9), 1558. |
| 1996 | Rischmueller, M., Burrows, S., Moss, D., Gordon, T., Coates, T., & McCluskey, J. (1996). Evidence for normal T cell tolerance in primary Sjogren's syndrome. ARTHRITIS AND RHEUMATISM, 39(9), 1559. |
| 1996 | Beer, R., Rischmueller, M., Coates, T., Purcell, A., Keech, C., McCluskey, J., & Gordon, T. (1996). Nonprecipitating anti-La (SS-B) autoantibodies in primary Sjögren's syndrome. Clinical Immunology and Immunopathology, 79(3), 314-318. Scopus35 Europe PMC23 |
| 1996 | Keech, C., Howarth, S., Coates, T., Rischmueller, M., McCluskey, J., & Gordon, T. (1996). Rapid and sensitive detection of anti-Ro (SS-A) antibodies by indirect immunofluorescence of 60kDa Ro Hep-2 transfectants. Pathology, 28(1), 54-57. Scopus28 Europe PMC16 |
| 1995 | Rischmueller, M., McNeilage, L. J., McCluskey, J., & Gordon, T. (1995). Human autoantibodies directed against the RNA recognition motif of La (SS-B) bind to a conformational epitope present on the intact La (SS-B)/Ro (SS-A) ribonucleoprotein particle. Clinical and Experimental Immunology, 101(1), 39-44. Scopus15 WoS14 Europe PMC11 |
| 1994 | Gordon, T., Topfer, F., Keech, C., Reynolds, P., Chen, W., Rischmueller, M., & Mccluskey, J. (1994). How does autoimmunity to la and ro initiate and spread?. Autoimmunity, 18(2), 87-92. Scopus18 WoS18 Europe PMC12 |
| 1992 | Roberts-Thomson, P. J., Rischmueller, M., Kwiatek, R. A., Soden, M., Ahern, M. J., Hill, W. R., & Geddes, R. A. (1992). Rheumatic manifestations of infective endocarditis. Rheumatology International, 12(2), 61-63. Scopus30 Europe PMC17 |
| Year | Citation |
|---|---|
| 2020 | Rischmueller, M., Downie-Doyle, S., & Fitridge, R. (2020). Pathophysiology and Principles of Management of Vasculitis and Fibromuscular Dysplasia. In Mechanisms of Vascular Disease A Textbook for Vascular Specialists Third Edition (pp. 361-393). Springer International Publishing. DOI Scopus1 |
| Year | Citation |
|---|---|
| 2022 | Nagel, A., Khatri, B., Radziszewski, M., Wiley, M., Stolarczyk, A., Joachims, M., . . . Lessard, C. (2022). Autophagy-related Risk Loci in Systemic Lupus Erythematous and Sjogren's Disease. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3982-3983). PA, Philadelphia: WILEY. |
| 2022 | Wiley, M., Khatri, B., Tessneer, K., Joachims, M., Stolarczyk, A., Nagel, A., . . . Lessard, C. (2022). Fine Mapping of the Sjogren's Disease and Systemic Lupus Erythematosus <i>DDX6</i>-<i>CXCR5</i> Risk Interval Reveals Common SNPs with Functional Significance in Immune and Salivary Gland Cells. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3981-3982). PA, Philadelphia: WILEY. |
| 2022 | Merriman, T., Matsuo, H., Takei, R., Leask, M., Topless, R., Shirai, Y., . . . Major, T. (2022). A Genome-Wide Association Analysis of 2,622,830 Individuals Reveals New Pathogenic Pathways in Gout. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3338-3341). PA, Philadelphia: WILEY. |
| 2022 | Radziszewski, M., Wiley, M., Khatri, B., Tessneer, K., Rasmussen, A., Bowman, S., . . . Lessard, C. (2022). Transcriptome-Wide Association Study of Sjogren's Disease Risk Alleles Identifies Novel Genes with Altered Expression in Minor Salivary Gland and Other Tissues. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 2223-2225). PA, Philadelphia: WILEY. |
| 2022 | Wiley, M. M., Khatri, B., Tessneer, K. L., Joachims, M. L., Stolarczyk, A. M., Nagel, A., . . . Lessard, C. (2022). SJOGREN'S DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS DDX6-CXCR5 RISK INTERVALS REVEAL COMMON SNPS WITH FUNCTIONAL SIGNIFICANCE IN IMMUNE AND SALIVARY GLAND CELLS. In ANNALS OF THE RHEUMATIC DISEASES Vol. 81 (pp. 269-270). DENMARK, Copenhagen: ELSEVIER. DOI WoS1 |
| 2022 | Aghakhanian, F., Wiley, M. M., Khatri, B., Tessneer, K. L., Rasmussen, A., Bowman, S. J., . . . Lessard, C. (2022). INTEGRATION OF GWAS AND EPIGENETIC STUDIES IDENTIFIES NOVEL GENES THAT ALTER EXPRESSION IN THE MINOR SALIVARY GLAND IN SJOGREN'S DISEASE. In ANNALS OF THE RHEUMATIC DISEASES Vol. 81 (pp. 72-73). DENMARK, Copenhagen: ELSEVIER. DOI |
| 2022 | Kivitz, A., Wells, A. F., Vargas, J. I., Baraf, H. S. B., Rischmueller, M., Klaff, J., . . . Durez, P. (2022). LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 81 (pp. 620-621). DENMARK, Copenhagen: ELSEVIER. DOI |
| 2022 | Khoo, T., Lester, S., Hill, C., Whittle, S., Black, R., Tieu, J., & Rischmueller, M. (2022). CONNECTIVE TISSUE DISEASE RELATED INTERSTITIAL LUNG DISEASE IN A RHEUMATOLOGY CLINIC POPULATION. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 35). WILEY. |
| 2022 | Chin, A., Lester, S., Khoo, T., Burnet, S., Tieu, J., Rischmueller, M., . . . Hill, C. (2022). LYMPHOPAENIA IN RHEUMATOID ARTHRITIS (RA): A SINGLE CENTRE AUDIT. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 29). WILEY. |
| 2022 | Hutton, I., Rischmueller, M., Bird, P., Latymer, M., Gruben, D., & Thorat, A. (2022). USABILITY AND ACCEPTABILITY OF A NEW AUTOINJECTOR DEVICE AND ITS ASSOCIATED APP IN AUSTRALIAN RHEUMATOLOGY PATIENTS. In INTERNAL MEDICINE JOURNAL Vol. 52 (pp. 24-25). WILEY. |
| 2022 | Radziszewski, M., Wiley, M., Khatri, B., Tessneer, K., Rasmussen, A., Bowman, S. J., . . . Lessard, C. J. (2022). TRANSCRIPTOME-WIDE ASSOCIATION STUDY OF SJOGREN'S DISEASE RISK ALLELES IDENTIFIES NOVEL GENES WITH ALTERED EXPRESSION IN MINOR SALIVARY GLAND AND OTHER TISSUES. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 17). CLINICAL & EXPER RHEUMATOLOGY. |
| 2022 | Wiley, M., Khatri, B., Tessneer, K., Joachims, M., Stolarczyk, A., Nagel, A., . . . Lessard, C. J. (2022). FINE MAPPING OF THE DDX6-CXCR5 RISK INTERVAL REVEALS SNPS IN SJOGREN'S DISEASE WITH FUNCTIONAL SIGNIFICANCE IN IMMUNE CELLS AND SALIVARY GLAND. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 14). CLINICAL & EXPER RHEUMATOLOGY. |
| 2022 | Nagel, A., Khatri, B., Radziszewski, M., Wiley, M., Stolarczyk, A., Joachims, M., . . . Lessard, C. J. (2022). AUTOPHAGY-RELATED PRDM1-ATG5 RISK LOCUS IN SJOGREN'S DISEASE. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 26). CLINICAL & EXPER RHEUMATOLOGY. |
| 2022 | Retamozo, S., Szanto, A., Li, X., Rasmussen, A., Ng, F., Dong, X., . . . Ramos-Casals, M. (2022). INFLUENCE OF EPIDEMIOLOGY AND ETHNICITY ON SYSTEMIC EXPRESSION OF PRIMARY SJOGREN SYNDROME AT DIAGNOSIS: WORLDWIDE PATTERNS IN 14,836 PATIENTS (2022 SJOGREN BIG DATA PROJECT). In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 57). CLINICAL & EXPER RHEUMATOLOGY. |
| 2022 | Flores-Chavez, A., Horvath, F. I., Li, X., Rasmussen, A., Ng, F., Dong, X., . . . Akasbi, M. (2022). KEY FEATURES AT DIAGNOSIS OF PRIMARY SJOGREN SYNDROME IN 15,652 PATIENTS: 2022 SJOGREN BIG DATA PROJECT. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 40 (pp. 93). CLINICAL & EXPER RHEUMATOLOGY. |
| 2021 | Rubbert-Roth, A., Xavier, R., Haraoui, B., Baraf, H. S. B., Rischmueller, M., Martin, N., . . . Cush, J. (2021). CLINICAL RESPONSES TO UPADACITINIB OR ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS BY TYPE OF PRIOR BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG: DATA FROM THE PHASE 3 SELECT-CHOICE STUDY. In ANNALS OF THE RHEUMATIC DISEASES Vol. 80 (pp. 580). BMJ PUBLISHING GROUP. DOI WoS2 |
| 2020 | Quinlivan, A., Downie-Doyle, S., Lester, S., Gordon, T., & Rischmueller, M. (2020). OBSERVATIONS FROM AN AUSTRALIAN SJOGREN'S COHORT. In INTERNAL MEDICINE JOURNAL Vol. 50 (pp. 28). WILEY. |
| 2019 | van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Mohamed, M. F., Chen, S., . . . Strand, V. (2019). A PHASE 3, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING UPADACITINIB MONOTHERAPY TO MTX MONOTHERAPY IN MTX-NAIVE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. In JCR-JOURNAL OF CLINICAL RHEUMATOLOGY Vol. 25 (pp. S4). LIPPINCOTT WILLIAMS & WILKINS. |
| 2019 | van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Mohamed, F., Chen, S., . . . Strand, V. (2019). A PHASE 3, RANDOMISED CONTROLLED TRIAL COMPARING UPADACITINIB MONOTHERAPY TO MTX MONOTHERAPY IN MTX-NAIVE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS. In RHEUMATOLOGY Vol. 58 (pp. 64). Birmingham, ENGLAND: OXFORD UNIV PRESS. WoS2 |
| 2018 | Khanam, S., Joachims, M. L., Means, N., Adrianto, I., Rasmussen, A., Bowman, S. J., . . . Lessard, C. J. (2018). Functional characterization of the Sjogren's syndrome-associated locus <i>DDX6</i>-<i>CXCR5</i>. In CLINICAL AND EXPERIMENTAL RHEUMATOLOGY Vol. 36 (pp. S286-S287). CLINICAL & EXPER RHEUMATOLOGY. |
| 2018 | Khanam, S., Joachims, M. L., Means, N., Omdal, R., Wahren-Herlenius, M., Alevizos, I., . . . Lessard, C. (2018). FUNCTIONAL CHARACTERIZATION OF THE SJOGREN'S SYNDROME-ASSOCIATED LOCUS DDX6-CXCR5. In ANNALS OF THE RHEUMATIC DISEASES Vol. 77 (pp. 1267). Amsterdam, NETHERLANDS: BMJ PUBLISHING GROUP. DOI |
| 2018 | van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Mohamed, M. -E., Chen, S., . . . Strand, V. (2018). A Phase 3, Randomized, Controlled Trial Comparing Upadacitinib Monotherapy to MTX Monotherapy in MTX-Naive Patients with Active Rheumatoid Arthritis. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 3 pages). IL, Chicago: WILEY. WoS5 |
| 2018 | Tesser, J., St John, G., Kimura, T., Fiore, S., Rischmueller, M., Maldonado-Cocco, J. A., . . . Kaine, J. (2018). Liver Function Test Levels with Sarilumab Treatment in Phase 3 Trials: Analysis By Baseline Liver Function Test (LFT) Level. In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 3 pages). IL, Chicago: WILEY. |
| 2018 | Retamozo, S., Acar-Denizli, N., Ng, W. -F., Zeher, M., Rasmussen, A., Mandl, T., . . . Brito-Zeron, P. (2018). How Immunological Profile Drives Clinical Phenotype of Primary Sjogren's Syndrome at Diagnosis: Analysis of 10.500 Patients (Sjogren Big Data Project). In ARTHRITIS & RHEUMATOLOGY Vol. 70 (pp. 2 pages). IL, Chicago: WILEY. |
| 2016 | Bird, P., Rischmueller, M., Feletar, M., Grant, G., Staples, M. P., & Hall, S. (2016). Real World Treat to Target Strategy in Rheumatoid Arthritis: Radiograph and MRI Outcomes in Three Cohorts with 18 Month Follow up. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 2 pages). DC, Washington: WILEY. |
| 2016 | Hall, S., Nash, P., Rischmueller, M., Wiid, Z., Witcombe, D., Gruben, D., . . . Lukic, T. (2016). Efficacy of Tofacitinib in Patients Who Are Inadequate Responders to Disease-Modifying Antirheumatic Drugs According to Early Versus Late Duration of Rheumatoid Arthritis: Post-Hoc Analysis of Data from Phase 3 Trials. In ARTHRITIS & RHEUMATOLOGY Vol. 68 (pp. 3 pages). DC, Washington: WILEY. WoS2 |
| 2014 | Merriman, T., Topless, R., Day, R., Kannangara, D., Williams, K., Bradbury, L., . . . Rasheed, H. (2014). ASSOCIATION OF THE TOLL-LIKE RECEPTOR 4 (TLR4) GENE WITH GOUT. In ANNALS OF THE RHEUMATIC DISEASES Vol. 73 (pp. 354). Paris, FRANCE: BMJ PUBLISHING GROUP. DOI WoS2 |
| 2013 | Liu, K., Kaufman, K. M., James, J. A., Jonsson, R., Kurien, B. T., Mariette, X., . . . Scofield, R. H. (2013). Sex Bias In Autoimmune Diseases: Increased Risk Of 47,XXX In Systemic Lupus Erythematosus (SLE) and Sjogren's Syndrome (SS) Supports The Gene Dose Hypothesis. In ARTHRITIS AND RHEUMATISM Vol. 65 (pp. S379). San Diego, CA: WILEY-BLACKWELL. WoS2 |
| 2012 | Lessard, C. J., Li, H., Adrianto, I., Ice, J. A., Jonsson, R., Illei, G. G., . . . Sivils, K. M. (2012). A Genome-Wide Association Study Establishes Muliple Susceptibility Loci for Sjogren's Syndrome. In ARTHRITIS AND RHEUMATISM Vol. 64 (pp. S1133). Washington, DC: WILEY-BLACKWELL. WoS2 |
| 2011 | Nossent, J. C., Rischmueller, M., Becker-Merok, A., & Lester, S. (2011). Interferon-Alpha Activation in Relation to Pro-Inflammatory Cytokines and Anti-Ro/La Response in Primary Sjogren's Syndrome. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S186). Chicago, IL: WILEY. |
| 2011 | Nossent, J. C., Rischmueller, M., Becker-Merok, A., & Lester, S. (2011). Low Copy Number of Fcgamma Receptor 3B Gene Is a Disease Susceptibility and Severity Factor in Primary Sjogren's Syndrome. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S389). Chicago, IL: WILEY. WoS2 |
| 2011 | Lessard, C. J., Ice, J. A., Adrianto, I., Kelly, J. A., Jonsson, R., Illei, G. G., . . . Moser, K. L. (2011). A High-Density Genome-Wide Association Study by the Sjogren's Genetics Network Identifies Five Novel Susceptibility Loci for Primary Sjogren's Syndrome and Confirms Association with <i>MHC</i>, <i>IRF5</i>, and <i>BLK</i>. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S184). Chicago, IL: WILEY. WoS2 |
| 2011 | Lessard, C. J., Adrianto, I., Ice, J. A., Kelly, J. A., Jonsson, R., Illei, G. G., . . . Moser, K. L. (2011). Large-Scale, High-Density Genotyping Performed by the Sjogren's Genetics Network Using the ImmunoChip Identifies <i>PRKRA</i> as a Novel Sjogren's Syndrome Susceptibility Locus and Confirms Associations with IRF5, BLK and MHC. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S303-S304). Chicago, IL: WILEY. |
| 2011 | Usmani, Z. A., Catcheside, P., Antic, N., Rischmueller, M., Smith, M., Gordon, T., & Mcevoy, R. D. (2011). Surfactant for OSA in patients with primary Sjogren's syndrome-a randomised, placebo controlled, cross over study. In JOURNAL OF SLEEP RESEARCH Vol. 20 (pp. 43). Sydney, AUSTRALIA: WILEY-BLACKWELL. |
| 2011 | Dillon, S. P., Kao, L., Kaufman, K. M., Ice, J. A., Omdal, R., Mariette, X., . . . Scofield, R. H. (2011). Triple X Syndrome (47,XXX) Increases the Risk and Accelerates the Onset of Systemic Lupus Erythematosus and Sjogren's Syndrome: Support for a Gene-Dose Effect From the X Chromosome. In ARTHRITIS AND RHEUMATISM Vol. 63 (pp. S251). Chicago, IL: WILEY. WoS2 |
| 2008 | Cobb, B. L., Wang, Y., Kaufman, K. M., Guthridge, J., Jonsson, R., Bolstad, A. I., . . . Harley, J. B. (2008). Association of BLK with Sjogren's syndrome (SS) and systemic lupus erythematosus (SLE) initially identified by whole genome DNA pooling. In ARTHRITIS AND RHEUMATISM Vol. 58 (pp. S791). San Francisco, CA: WILEY-LISS. |
| 2008 | Lester, S., Skarratt, K., Gu, B., Downie-Doyle, S., Wiley, J., & Rischmueller, M. (2008). Functional polymorphisms of the P2x<sub>7</sub> gene influence susceptibility to Ro/la autoantibody-positive primary Sjogren's syndrome. In ARTHRITIS AND RHEUMATISM Vol. 58 (pp. S792). San Francisco, CA: WILEY-LISS. WoS1 |
| 2007 | Nossent, J. C., Rischmueller, M., Zahra, D., Mackay, C., & Lester, S. (2007). Haploid genotypes in the promoter region of the B-lymphocyte activating factor gene are associated with disease susceptibility and increased serum BAFF levels in anti-RO/LA antibody positive primary Sjogren's syndrome. In ANNALS OF THE RHEUMATIC DISEASES Vol. 66 (pp. 135). Barcelona, SPAIN: B M J PUBLISHING GROUP. |
| 2006 | Cai, F. Z., Lester, S. E., Lu, T., Keen, H., & Rischmueller, M. (2006). Autonomic dysfunction in primary Sjogren's syndrome: A controlled study.. In ARTHRITIS AND RHEUMATISM Vol. 54 (pp. S252). Washington, DC: WILEY-LISS. |
| 2006 | Downie, S., Bayat, N., Rischmueller, M., & Lester, S. (2006). Influence of CTLA-4 haplotypes upon susceptibility and extraglandular manifestations in australian patients with primary Sjogren's syndrome. In ANNALS OF THE RHEUMATIC DISEASES Vol. 65 (pp. 286). Amsterdam, NETHERLANDS: B M J PUBLISHING GROUP. |
| 2003 | Rischmueller, M. (2003). Humoral, hormonal and genetic determinants of cholinergic dysfunction in Sogren's syndrome. In ARTHRITIS RESEARCH & THERAPY Vol. 5 (pp. S50). Miyakazi, JAPAN: BIOMED CENTRAL LTD. DOI |
| 2003 | Roberts-Thomson, P. J., Male, D., Walker, J. G., Cox, S., Rischmueller, M., Pile, K., . . . Turner, D. (2003). Genetic instability in scleroderma. In ANNALS OF THE RHEUMATIC DISEASES Vol. 62 (pp. 104). LISBON, PORTUGAL: B M J PUBLISHING GROUP. |
| 2003 | Whittle, S., Lester, S. E., Downie-Doyle, S., Pile, K. D., & Rischmueller, M. (2003). Estrogen receptor alpha IVS1-401 (T/C) polymorphism in primary Sjogren's syndrome.. In ARTHRITIS AND RHEUMATISM Vol. 48 (pp. S567). ORLANDO, FLORIDA: WILEY-LISS. |
| 1999 | Limaye, V., Lester, S., Downie, S., Pile, K., Bardy, P., Gordon, T. P., & Rischmueller, M. (1999). The interleukin-10 GCC promoter is not associated with anti-Ro autoantibodies in primary Sjogren's syndrome. In ARTHRITIS AND RHEUMATISM Vol. 42 (pp. S139). LIPPINCOTT WILLIAMS & WILKINS. |
| 1997 | McCluskey, J., Reynolds, P., Rischmueller, M., Keech, C., Lester, S., & Gordon, T. P. (1997). Incompletetolerance to nuclear self-antigens: a model for HLA-restricted induction and diversification of autoantibodies in systemic autoimmunity. In D. Charron (Ed.), HLA - GENETIC DIVERSITY OF HLA FUNCTIONAL AND MEDICAL IMPLICATION, PROCEEDINGS OF THE TWELFTH INTERNATIONAL HISTOCOMPATIBILITY WORKSHOP AND CONFERENCE (12TH IHWC), VOL II: CONFERENCE (pp. 48-59). ST MALO, FRANCE: EDITIONS EDK. |
| Year | Citation |
|---|---|
| 2022 | Fairley, J., Hansen, D., Ross, L., Proudman, S., Sahhar, J., Ngian, G. -S., . . . Nikpour, M. (2022). Clinical Characteristics and Survival of Combined Pulmonary Arterial Hypertension and Interstitial Lung Disease in Systemic Sclerosis. Poster session presented at the meeting of Abstracts of the ACR Convergence 2022, as published in Arthritis & Rheumatology. Philadelphia, PA: Wiley. DOI |
| 2020 | van Vollenhoven, R., Takeuchi, T., Pangan, A. L., Friedman, A., Chen, S., Rischmueller, M., . . . Strand, V. (2020). MONOTHERAPY WITH UPADACITINIB IN MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS. Poster session presented at the meeting of JCR-JOURNAL OF CLINICAL RHEUMATOLOGY. LIPPINCOTT WILLIAMS & WILKINS. |
| 2020 | Singh, M., Jackson, K., Wang, J. J., Schofield, P., Field, M., Rischmueller, M., . . . Reed, J. (2020). GENOMIC ANALYSIS OF B CELLS PRODUCING PATHOGENIC RHEUMATOID FACTORS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2020 | Rubbert-Roth, A., Enejosa, J., Pangan, A., Xavier, R., Haraoui, B., Rischmueller, M., . . . Genovese, M. C. (2020). EFFICACY AND SAFETY OF UPADACITINIB VERSUS ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-CHOICE): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: ELSEVIER. DOI WoS10 |
| 2020 | Khatri, B., Reksten, T. R., Tessneer, K. L., Rasmussen, A., Scofield, R. H., Bowman, S. J., . . . Lessard, C. (2020). GENOME-WIDE ASSOCIATION STUDY OF SJOGREN'S SYNDROME IDENTIFIES TEN NEW RISK LOCI. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: BMJ PUBLISHING GROUP. DOI WoS7 |
| 2020 | Van Vollenhoven, R., Takeuchi, T., Rischmueller, M., Blanco, R., Xavier, R., Howard, M., . . . Strand, V. (2020). UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM SELECT-EARLY. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: BMJ PUBLISHING GROUP. DOI WoS2 |
| 2020 | Verstappen, G. M., Tempany, J. C., Cheon, H., Farchione, A., Downie-Doyle, S., Rischmueller, M., . . . Bryant, V. L. (2020). STRATIFICATION OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME BY MEASURING B-CELL HEALTH. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: BMJ PUBLISHING GROUP. DOI |
| 2020 | Wiley, M. M., Khatri, B., Tessneer, K. L., Joachims, M. L., Stolarczyk, A. M., Rasmussen, A., . . . Lessard, C. (2020). FUNCTIONAL EVALUATION OF THE SJOGREN'S SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS DDX6-CXCR5 RISK INTERVAL. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. ELECTR NETWORK: BMJ PUBLISHING GROUP. DOI |
| 2020 | Khatri, B., Reksten, T. R., Tessneer, K., Rasmussen, A., Scofield, R., Bowman, S., . . . Lessard, C. (2020). Genome-wide Association Study of Sjogren's Syndrome Identifies Ten New Risk Loci. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. ELECTR NETWORK: WILEY. |
| 2020 | van Vollenhoven, R., Takeuchi, T., Rischmueller, M., Blanco, R., Xavier, R., Howard, M., . . . Strand, V. (2020). Upadacitinib Monotherapy in Methotrexate-naive Patients with Rheumatoid Arthritis: Results at 72 Weeks. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. ELECTR NETWORK: WILEY. |
| 2019 | Fairley, J., Hansen, D., Proudman, S., Sahhar, J., Ngian, G. -S., Walker, J., . . . Nikpour, M. (2019). Clinical Characteristics and Survival in Systemic Sclerosis-mixed Connective Tissue Disease and Systemic Sclerosis-overlap Syndrome. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. GA, Atlanta: WILEY. |
| 2019 | van Vollenhoven, R., Takeuchi, T., Pangan, A., Friedman, A., Chen, S., Rischmueller, M., . . . Strand, V. (2019). Monotherapy with Upadacitinib in MTX-naive Patients with Rheumatoid Arthritis: Results at 48 Weeks. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. GA, Atlanta: WILEY. |
| 2019 | van Vollenhoven, R., Takeuchi, T., Pangan, A., Friedman, A., Chen, S., Rischmueller, M., . . . Strand, V. (2019). MONOTHERAPY WITH UPADACITINIB IN MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-EARLY STUDY. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP. DOI WoS6 |
| 2018 | March, L., Willers, C., Ellis, J., Cobb, J., Lester, S., Buchbinder, R., . . . Murray, K. (2018). THE AUSTRALIAN ARTHRITIS AND AUTOIMMUNE BIOBANK COLLABORATIVE (A3BC) PROTOCOL. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2018 | Vincent, F., Kandane-Rathnayake, R., Hoi, A., Slavin, L., Godsell, J., Kitching, A. R., . . . Morand, E. (2018). URINARY B CELL-ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR FAMILY (BAFF) IN SYSTEMIC LUPUS ERYTHEMATOSUS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY. |
| 2017 | Merriman, T. R., Cadzow, M., Merriman, M. E., Phipps-Green, A., Topless, R., Abhishek, A., . . . Major, T. (2017). A Genome-Wide Association Study of Gout in People of European Ancestry. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY. |
| 2017 | Retamozo, S., Brito-Zeron, P., Zeher, M., Sivils, K. L., Seror, R., Mandl, T., . . . Ramos-Casals, M. (2017). Epidemiologic Subsets Drive a Differentiated Clinical and Immunological Presentation of Primary Sjogren Syndrome: Analysis of 9302 Patients from the Big Data International Sjogren Cohort. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY. WoS3 |
| 2017 | Walker, J. G., Nikpour, M., Huq, M., Patterson, K., Roberts-Thomson, P., Proudman, S., . . . Fritzler, M. J. (2017). Autoantibodies to the hPOP1 and Rpp25/38 Components of the Th/to Complex Identify a Subgroup of Systemic Sclerosis (SSc) Associated Interstitial Lung Disease (ILD) and Antibodies to hPOP1 Are Associated with Reduced Survival. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Diego: WILEY. |
| 2017 | Brito-Zeron, P., Acar-Denizli, N., Zeher, M., Rasmussen, A., Li, X., Baldini, C., . . . Ramos-Casals, M. (2017). BASELINE ESSDAI/ DAS SCORES IN 8061 PATIENTS WITH PRIMARY SJOGREN SYNDROME: CHARACTERIZATION OF SYSTEMIC DISEASE. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP. DOI WoS1 |
| 2017 | Brito-Zeron, P., Acar-Denizli, N., Zeher, M., Rasmussen, A., Li, X., Baldini, C., . . . Ramos-Casals, M. (2017). PREDICTING SURVIVAL IN 6240 PATIENTS WITH PRIMARY SJOGREN' SYNDROME (BIG DATA SJOGREN PROJECT). Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP. DOI |
| 2017 | Merriman, T. R., Cadzow, M., Merriman, M., Phipps-Green, A., Topless, R., Abhishek, A., . . . Flynn, T. (2017). A GENOME-WIDE ASSOCIATION STUDY OF GOUT IN PEOPLE OF EUROPEAN ANCESTRY. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP. DOI |
| 2017 | Brito-Zeron, P., Acar-Denizli, N., Zeher, M., Rasmussen, A., Seror, R., Mandl, T., . . . Ramos-Casals, M. (2017). ANALYSIS OF 9302 PATIENTS FROM THE BIG DATA INTERNATIONAL PRIMARY SJOGREN SYNDROME COHORT: CLINICAL PRESENTATION AT DIAGNOSIS OF EUROPEAN VS NON-EUROPEAN PATIENTS. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. Madrid, SPAIN: BMJ PUBLISHING GROUP. DOI |
| 2016 | Lau, A. H. Y., Lester, S., Moraitis, S., Ou, J., Rischmueller, M., Wormald, P. J., & Vreugde, S. (2016). Tertiary Lymphoid Organ in Chronic Rhinosinusitis. Poster session presented at the meeting of 2016 ASMR South Australian Scientific Meeting. Convention Centre, Adelaide, South Australia, Australia. |
| 2016 | Joachims, M. L., Adrianto, I., Johnston, A., Ice, J., Rasmussen, A., Bowman, S., . . . Lessard, C. J. (2016). Identification and Characterization of Sjogren's Syndrome-Associated Genetic Variants in the IL12A and DDX6-CXCR5 Loci. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. |
| 2016 | Lessard, C. J., Adrianto, I., Ice, J., Rasmussen, A., Grundahl, K., Kelly, J. A., . . . Sivils, K. L. (2016). Genome-Wide Association Study Identifies Novel Sjogren's Syndrome Risk Loci in the Regions of NAB1, TYK2, and PTTG1-mir146a. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. |
| 2016 | Lessard, C., Li, H., Ice, J. A., Adrianto, I., Rasmussen, A., Lewis, D. M., . . . Sivils, K. L. (2016). IDENTIFICATION OF SJOGREN'S SYNDROME RISK LOCI NEAR TNFAIP3 AND PRDM1. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. London, ENGLAND: BMJ PUBLISHING GROUP. DOI |
| 2016 | Hsu, V., Denton, C. P., Domsic, R. T., Furst, D. E., Rischmueller, M., Stanislav, M., . . . Choi, S. (2016). A Phase 2 Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness in Subjects with Systemic Sclerosis with Interstitial Lung Disease. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. WoS1 |
| 2016 | Sharma, R., Harris, V. M., Cavett, J., Kurien, B. T., Liu, K., Koelsch, K. A., . . . Miceli-Richard, C. (2016). Very Rare X Chromosome Abnormalities in SLE and SjoGren's May Localize X Gene Dose Effect. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. DC, Washington: WILEY. |
| 2015 | Lessard, C., Li, H., Ice, J. A., Adrianto, I., Montgomery, C. G., Alevizos, I., . . . Sivils, K. L. (2015). IDENTIFICATION OF A SJOGREN'S SYNDROME-ASSOCIATED VARIANT THAT INFLUENCES OAS1 ISOFORM SWITCHING AND PROTEIN EXPRESSION. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. BMJ PUBLISHING GROUP. DOI |
| 2015 | Maundrell, A., Wiese, M., Lester, S., Rischmueller, M., Cleland, L., Blumbergs, P., & Limaye, V. (2015). SINGLE NUCLEOTIDE POLYMORPHISMS IN THE PROTEIN TYROSINE PHOSPHATASE (PTPN22) GENE ARE ASSOCIATED WITH SUSCEPTIBILITY TO IDIOPATHIC INFLAMMATORY MYOSITIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2015 | Lau, A., Bosco, M., Lester, S., Roscioli, E., Zalewski, P., & Rischmueller, M. (2015). ARA3 Inflammasome activation in salivary gland epithelial cells - a disease model for primary sjögren's syndrome. Poster session presented at the meeting of Abstracts of the Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting, as published in Internal Medicine Journal. Adelaide, South Australia: Wiley. DOI |
| 2015 | Wechalekar, M., Lester, S., Rischmueller, M., Hill, C., & Proudman, S. (2015). FOOT SYNOVITIS IN PATIENTS IN APPARENT REMISSION IS ASSOCIATED WITH WORSE LONG-TERM FUNCTIONAL OUTCOMES. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2015 | Wodkowski, M., Hudson, M., Proudman, S., Walker, J., Stevens, W., Nikpour, M., . . . Fritzler, M. (2015). Clinical Correlates of Monospecific Anti-Ro52/TRIM21 Antibodies in a Tri-nation Cohort of 1574 Systemic Sclerosis Subjects. Poster session presented at the meeting of JOURNAL OF RHEUMATOLOGY. Quebec, CANADA: J RHEUMATOL PUBL CO. |
| 2015 | Lessard, C. J., Li, H., Ice, J., Adrianto, I., Rasmussen, A., Grundahl, K., . . . Sivils, K. L. (2015). Identification of Novel Sjogren's Syndrome Risk Loci in the Regions of TNFAIP3 and PRDM1. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY. |
| 2015 | Harris, V. M., Cavett, J., Kurien, B., Liu, K., Koelsch, K. A., Radfar, L., . . . Scofield, R. H. (2015). Klinefelter's Syndrome (47,XXY) Among Men with Sjogren's Syndrome. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. CA, San Francisco: WILEY-BLACKWELL. |
| 2014 | Hao, Y., Thakkar, V., Stevens, W., Morrisroe, K., Prior, D., Rabusa, C., . . . Nikpour, M. (2014). A COMPARISON OF THE PREDICTIVE ACCURACY OF THREE SCREENING MODELS (DETECT V. ESC/ERS V. ASIG) FOR PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC SCLEROSIS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. Hobart, Tasmania: WILEY-BLACKWELL. |
| 2014 | Rasheed, H., Topless, R., Day, R., Kannangara, D., Williams, K., Bradbury, L., . . . Merriman, T. R. (2014). Association of the Toll-like Receptor 4 (TLR4) Gene with Gout.. Poster session presented at the meeting of ARTHRITIS & RHEUMATOLOGY. MA, Boston: WILEY. |
| 2014 | Kremer, J., Halland, A., Rischmueller, M., Major, G., Taylor, A., Brzosko, M., . . . Fleischmann, R. (2014). LITHE: 5-YEAR FOLLOW-UP DATA DEMONSTRATE MAINTENANCE OF CLINICAL EFFICACY OVER TIME WITH THE USE OF TOCILIZUMAN (TCZ) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) (ENCORE). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2014 | Genovese, M., Sebba, A., Youssef, P., Rischmueller, M., Jones, G., Rubbert-Roth, A., . . . Van Vollenhoven, R. (2014). LONG-TERM SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING A MEAN TREATMENT DURATION OF 3.9 YEARS (ENCORE). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2014 | Liu, K., Kurien, B., Zimmerman, S., Kaufman, K., Mariette, X., Kottyan, L., . . . Scofield, R. (2014). X chromosome dose and sex bias in autoimmune diseases: increased 47,XXX in systemic lupus erythematosus and Sjogren's syndrome. Poster session presented at the meeting of JOURNAL OF IMMUNOLOGY. AMER ASSOC IMMUNOLOGISTS. WoS1 |
| 2014 | Hall, S., Nash, P., Rischmueller, M., Bossingham, D., Cook, N., Witcombe, D., . . . Thirunavukkarasu, K. (2014). TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR: LONG-TERM EXTENSION STUDY OUTCOMES IN AN AUSTRALIAN RHEUMATOID ARTHRITIS POPULATION. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. WoS1 |
| 2014 | Hao, Y. J., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). A comparison of the predictive accuracy of three screening models (DETECT v.ESC/ERS v. ASIG) for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 3rd Systemic Sclerosis World Congress, as published in Clinical and Experimental Rheumatology. Rome, Italy: Clinical and Experimental Rheumatology. |
| 2014 | Quinlivan, A., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Abstracts of the 3rd Systemic Sclerosis World Congress, as published in Clinical and Experimental Rheumatology. Rome, Italy: Clinical and Experimental Rheumatology. |
| 2014 | Quinlivan, A., Thakkar, V., Stevens, W., Prior, D., Rabusa, C., Youssef, P., . . . Nikpour, M. (2014). Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell. DOI |
| 2014 | Lester, S., Patterson, K., Walker, J., Charlesworth, J., Stankovich, J., Stevens, W., . . . Zochling, J. (2014). Associations between HLA DRB1 alleles and autoantibodies in systemic sclerosis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell. DOI |
| 2014 | Patterson, K., Roberts-Thomson, P., Lester, S., Proudman, S., Rischmueller, M., Stevens, W., . . . Walker, J. (2014). Autoantibody associations among a well-characterized Australian systemic sclerosis (SSc) cohort. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals Association 55th Annual Scientific Meeting, as published in Internal Medicine Journal. Hobart, Tasmania: Wiley-Blackwell. DOI |
| 2013 | Lessard, C. J., Li, H., Ice, J. A., Adrianto, I., Jonsson, R., Illei, G. G., . . . Sivils, K. M. (2013). IDENTIFICATION OF MULTIPLE SJOGREN'S SYNDROME SUSCEPTIBILITY LOCI. Poster session presented at the meeting of ANNALS OF THE RHEUMATIC DISEASES. BMJ PUBLISHING GROUP. WoS2 |
| 2013 | Hall, S., Nash, P., Rischmueller, M., Bossingham, D., Cook, N., Witcombe, D., . . . Thirunavukkarasu, K. (2013). TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR: PATIENT REPORTED OUTCOMES IN AN AUSTRALIAN PHASE 3 RHEUMATOID ARTHRITIS STUDY POPULATION. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2013 | Hall, S., Bird, P., Rischmueller, M., Rubbert-Roth, A., Cantagrel, A., Leszczynski, P., . . . Burmester, G. (2013). SUMMACTA: A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY OF THE SAFETY AND EFFICACY OF TOCILIZUMAB SUBCUTANEOUS (SC) VERSUS TOCILIZUMAB INTRAVENOUS (IV), IN COMBINATION WITH TRADITIONAL DMARDS IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS (RA). Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2013 | Lessard, C. J., Li, H., Adrianto, I., Ice, J. A., Dozmorov, M. G., Jonsson, R., . . . Sivils, K. L. (2013). Complex Functional Effects Within The HLA Contribute To Sjogren's Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding.. Poster session presented at the meeting of ARTHRITIS AND RHEUMATISM. San Diego, CA: WILEY-BLACKWELL. |
| 2013 | Dunstan, E., Lester, S., Hewitt, A., Rischmueller, M., & Hill, C. (2013). NO ASSOCIATION BETWEEN FCGR3B, TLR4 AND SOUTH AUSTRALIAN BIOPSY-PROVEN GIANT CELL ARTERITIS PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2012 | Dunstan, E., Lester, S., Black, R., Davatchi, F., Nadji, A., Bayat, N., . . . Shahram, F. (2012). THE CTLA4 GENE IS A POTENTIAL DISEASE MODIFYING GENE IN BEHCET'S DISEASE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2012 | Charlesworth, J., Stankovich, J., Lewis, P., Byron, J., Stevens, W., Sahhar, J., . . . Zochling, J. (2012). An immunochip based interrogation of scleroderma susceptibility variants. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell. DOI |
| 2012 | Hall, S., Nash, P., Rischmueller, M., Bossingham, D., Cook, N., Kwok, K., & Thirunavukkarasu, K. (2012). TOFACITINIB (CP-690,550), AN ORAL JANUS KINASE INHIBITOR: POOLED PHASE 3 ANALYSIS IN AN AUSTRALIAN RHEUMATOID ARTHRITIS STUDY POPULATION. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. WoS1 |
| 2012 | Proudman, S., Spargo, L., Hall, C., McWilliams, L., Lee, A., Rischmueller, M., . . . Cleland, L. G. (2012). Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose. Poster session presented at the meeting of Abstracts of the 2012 ACR/ARHP Annual Meeting, as published in Arthritis & Rheumatology. Washington, D.C.: Wiley-Blackwell. DOI |
| 2012 | Graf, S., Lester, S., Nossent, H., Hill, C., Proudman, S., Lee, A., & Rischmueller, M. (2012). Low copy number of the FCGR3B gene and rheumatoid arthritis: a case control study and meta-analysis. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell. DOI |
| 2012 | Proudman, S., Spargo, L., Hall, C., McWilliams, L., Lee, A., Rischmueller, M., . . . Cleland, L. (2012). Fish oil in rheumatoid arthritis: a randomised, double blind trial comparing high dose with low dose. Poster session presented at the meeting of Australian Rheumatology Association in conjunction with Rheumatology Health Professionals 53rd Annual Scientific Meeting, as published in Internal Medicine Journal. Canberra, ACT: Wiley-Blackwell. DOI WoS5 |
| 2011 | Nossent, J., Rischmueller, M., Becker-Merok, A., & Lester, S. (2011). LOW COPY NUMBER OF FCGAMMARECEPTOR IIIB PREDISPOSES TO SJOGREN'S SYNDROME AS WELL AS SLE, BUT CONTRIBUTES TO DISEASE THROUGH DIFFERENT PATHWAYS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. |
| 2000 | Limaye, V., Lester, S., Downie-Doyle, S., Pile, K., Bardy, P., Gordon, T., & Rischmueller, M. (2000). The interleukin-10 GCC promoter is not associated with anti-Ro autoantibodies in primary Sjgren's syndrome. Poster session presented at the meeting of Abstracts of the Annual Scientific Meeting of the Australian Rheumatology Association. Hobart, Tasmania. |
| 2000 | Downie-Doyle, S., Lester, S., Bardy, P., Gordon, T., Rischmueller, M., & Pile, K. (2000). Immunoglobulin Kappa light chain gene alleles are not associated with primary Sjogren's Syndrome (SS). Poster session presented at the meeting of Arthritis & Rheumatism. Philadelphia, Pennsylvania: American College of Rheumatology. |
| 2000 | Pile, K., Rischmueller, M., Jaksic, W., Champion, G., McNeil, J., & Wickham, N. (2000). High dose chemotherapy without autologous stem cell reinfusion in the treatment of RA. Poster session presented at the meeting of Abstract Supplement - Arthritis & Rheumatism 2000 Annual Scientific Meeting. Philadelphia, USA: American College of Rheumatology. |
| 2000 | Lester, S., Downie-Doyle, S., Gordon, T., Bardy, P., Rischmueller, M., & Pile, K. (2000). The IL4-R a Q576R polymorphism is not associated with primary Sjogren's Syndrome (SS). Poster session presented at the meeting of Abstract supplement - Arthritis & Rheumatism 2000 Annual Scientific Meeting. Philadelphia, USA: American College of Rheumatology. |
Grants
| 2017 | The Hospital Research Foundation (HRF) Project Grant: “Australian Arthritis & Autoimmune Biobank Collaborative (A3BC)” ($223,000, 2017-2020). Hill CL, Rischmueller M, March LM. |
| 2017 | Australian Arthritis & Autoimmune Biobank Collaborative: “Establishment of BHI Biobank” ($150,000, 2017-2020). Hill CL, Rischmueller M, March LM. |
| 2013 | Arthritis Australia Project Grant. “Extraction of DNA from GCA patient biopsies”. ($25,000). Brown MA, Merriman T, Rischmueller M, Hewitt A, Harrison A, Hill C. |
| 2012 | Associate Investigator on an NHMRC project grant. “How does disruption of Serinc1 expression affect lymphocyte function and the development of autoimmunity?” Dr T Brodnicki, St Vincent’s Institute of Medical Research. |
| 2011 | Arthritis Australia Project Grant “The Australasian Arthritis Genomics Recruitment Collaborative: Infrastructure for establishing a quality clinical resource for genetic research.” ($50,000). Brown M, Merriman T, Rischmueller M. |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Principal Supervisor | Living with Sjögren's Disease: the Impact on Australian Patients | Doctor of Philosophy | Doctorate | Part Time | Ms Cristina Patricia Pelkas |
| 2025 | Principal Supervisor | Living with Sjgren's Disease: the Impact on Australian Patients | Doctor of Philosophy | Doctorate | Full Time | Ms Cristina Patricia Pelkas |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2015 - 2018 | Co-Supervisor | An Immunological Perspective of the Mucosal Inflammation in Chronic Rhinosinusitis – Lymphoid Neo-organogenesis and Humoral Immunity | Doctor of Philosophy | Doctorate | Full Time | Mr Aden Lau |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2016 - ongoing | Member | Australasian Society for Ultrasound Medicine | - | - |
| 2016 - ongoing | Member | EXcite Immunology Weekend (Pfizer) | National Industry Symposium Steering Committees | - |
| 2016 - ongoing | Member | 14th International Sjogren’s Syndrome Symposium Scientific Committee | - | - |
| 2015 - ongoing | Member | Scientific Review Subcommittee | Human Research Ethics Committee (TQEH/LMH/MH) | - |
| 2014 - ongoing | Member | Gout Special Interest Forum (Astra-Zeneca) | - | - |
| 2013 - ongoing | Member | Australian Medical Association | - | - |
| 2013 - ongoing | Secretary | Medical Staff Society | The Queen Elizabeth Hospital | - |
| 2007 - 2012 | Member | SA Advanced Rheumatology Trainee Selection Committee | Royal Australian College of Physicians | - |
Connect With Me
External Profiles
